Perfil
Richard A. F.
Dixon is the founder of 7 Hills Pharma LLC.
Prior to founding 7 Hills Pharma LLC, he worked as the Chief Scientific Officer & SVP-Research at Encysive Pharmaceuticals, Inc. from 1990 to 2011.
Before that, he was the Director & Head-Molecular Biology at Merck Sharp & Dohme Research Laboratories from 1988 to 1990.
Dixon received his undergraduate degree from Texas A&M University and his doctorate from Baylor College of Medicine.
Cargos activos de Richard A. F. Dixon
| Empresas | Cargo | Inicio |
|---|---|---|
7 Hills Pharma LLC
7 Hills Pharma LLC Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer treatment | Fundador | - |
Antiguos cargos conocidos de Richard A. F. Dixon.
| Empresas | Cargo | Fin |
|---|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Director Técnico/Científico/I+D | 29/04/2011 |
Merck Sharp & Dohme Research Laboratories | Director/Miembro de la Junta | 01/01/1990 |
Formación de Richard A. F. Dixon.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Health Technology |
Texas A&M University
Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Sharp & Dohme Research Laboratories | |
7 Hills Pharma LLC
7 Hills Pharma LLC Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer treatment | Health Technology |
- Bolsa de valores
- Insiders
- Richard A. F. Dixon
















